2013Inflammation and RegenerationOpen access

Peroxiredoxin triggers cerebral post-ischemic inflammation

Takash Shichita, Ryota Sakaguchi, Minako Ito, Taisuke Kondo, Akihiko Yoshimura

Open full text 1 citations

Abstract

Post-ischemic inflammation is an essential step in the progression of ischemic stroke. However, it has not been sufficiently clarified how post-ischemic inflammation begins. Brain is a sterile organ, but Toll-like receptor (TLR) 2 and TLR4 have a pivotal role in the initiation of inflammation. Some endogenous danger associated molecular patterns (DAMPs) are released from injured brain cells. Among them, high mobility group box 1 (HMGB1) and peroxiredoxin (Prx) family proteins are key initiators of post-ischemic inflammation. HMGB1 induces blood brain barrier breakdown at the hyperacute phase; on the other hand, Prxs directly activate infiltrating macrophage through TLR2/4 and induce inflammatory cytokines production at the acute phase. Thus, there is a time lag as well as functional differences between HMGB1 and Prxs. Novel neuroprotective treatment could be developed through more detailed elucidation of the regulation of post-ischemic inflammation.

Open-access reader

About this research paper

What this paper is about

Post-ischemic inflammation is an essential step in the progression of ischemic stroke. However, it has not been sufficiently clarified how post-ischemic inflammation begins. Brain is a sterile organ, but Toll-like receptor (TLR) 2 and TLR4 have a pivotal role in the initiation of inflammation. Some endogenous danger associated molecular patterns (DAMPs) are released from injured brain cells. Among them, high mobility group box 1 (HMGB1) and peroxiredoxin (Prx) family proteins are key initiators of post-ischemic inflammation. HMGB1 induces blood brain barrier breakdown at the hyperacute phase; on the other hand, Prxs directly activate infiltrating macrophage through TLR2/4 and induce inflammatory cytokines production at the acute phase. Thus, there is a time lag as well as functional differences between HMGB1 and Prxs. Novel neuroprotective treatment could be developed through more detailed elucidation of the regulation of post-ischemic inflammation.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Post-ischemic inflammation is an essential step in the progression of ischemic stroke. However, it has not been sufficiently clarified how post-ischemic inflammation begins. Brain is a sterile organ, but Toll-like receptor (TLR) 2 and TLR4 have a pivotal role in the initiation of inflammation. Some endogenous danger associated molecular patterns (DAMPs) are released from injured brain cells. Among them, high mobility group box 1 (HMGB1) and peroxiredoxin (Prx) family proteins are key initiators of post-ischemic inflammation. HMGB1 induces blood brain barrier breakdown at the hyperacute phase; on the other hand, Prxs directly activate infiltrating macrophage through TLR2/4 and induce inflammatory cytokines production at the acute phase. Thus, there is a time lag as well as functional differences between HMGB1 and Prxs. Novel neuroprotective treatment could be developed through more detailed elucidation of the regulation of post-ischemic inflammation.

Key concepts: HMGB1, Inflammation, Neuroprotection, TLR2, TLR4, Medicine, Damp, Neuroinflammation

Related papers

Back to paper searchBrowse research topicsOriginal source
Peroxiredoxin triggers cerebral post-ischemic inflammation — Research Paper | ScholarLens